A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials

Martin Berger, Yan Ning, Sebastian Stintzing, Volker Heinemann, Shu Cao, Wu Zhang, Dongyun Yang, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Diana Hanna, Shivani Soni, Alberto Puccini, Ryuma Tokunaga, Madiha Naseem, Francesca Battaglin, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis, Heinz-Josef Lenz (2020) A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials Eur J Cancer (IF: 7.1) 131 89-97

Links

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513926
http://www.ncbi.nlm.nih.gov/pubmed/32305727
http://dx.doi.org/10.1016/j.ejca.2020.02.048

Similar articles

Tools

Export to RIS